American Growth Fund, Inc. (Series 2)

NPX - Proxy Voting Record

From July 1, 2019 to June 30, 2020

Shareholder

Proposals / Identification

Cast its Vote

Recommendations of the

Cast its Vote for or

Date

Date Notified

Company

Symbol

CUSIP

Meeting Date

Voted on

Proposed

Yes or No

Board of Directors

Against Management

Voted

7/6/2019 GB Sciences Inc

GBLX

361544109

8/15/2019

1 The approval of the increase in the number of authorized capital shares from

Issuer

Yes

For

For

7/12/2019

400,000,000 to 600,000,000.

2 The ratification of the appointment of Soles, Heyn & Company LLP as the

Issuer

Yes

For

For

Corporation's independent accountants to audit the Corporation's financial

statements for the fiscal year ending March 31, 2020.

7/24/2019 NEPTUNE WELLNESS

NEPT

64079

L105

8/14/2019

1 DIRECTOR

Issuer

Yes

For

For

8/2/2019

SOLUTIONS INC.

Mr. John M. Moretz

Mr. Michael Cammarata

Mr. R.P. Schottenfeld

Dr. Ronald Denis

Mr. Philippe Trudeau

Ms. Hélène F. Fortin

2 Appointment of KPMG LLP as Auditors of the Corporation for the ensuing year

Issuer

Yes

For

For

and authorizing the Directors to fix their remuneration.

3 To consider and, if deemed appropriate, to pass, with or without variation, an

Issuer

Yes

For

For

ordinary resolution approving certain amendments to the Corporation's stock option

plan and equity incentive plan, and ratifying and confirming the grant of 7,800,000

options to purchase common shares of the Corporation to Michael Cammarata, as

more particularly described in the circular.

10/3/2019 Akerna

KERN

00973

W102

11/11/2019

1 DIRECTOR

Issuer

Yes

For All

For All

10/4/2019

Tahira Rehmatullah

Matthew R. Kane

2 Ratification of appointment of Marcum LLP.

Issuer

Yes

For

For

3 Advisory vote on 2019 executive compensation ("Say-on-Pay").

Issuer

Yes

For

For

4 Advisory vote on the frequency of future Say-on-Pay votes.

Issuer

Yes

3 Years

3 Years

10/1/2019 CHINESEINVESTORS.COM, INCCIXX

16947

Q203

11/16/2019

1a ELECTION OF DIRECTOR: WARREN WANG

Issuer

Yes

For

For

10/4/2019

1b ELECTION OF DIRECTOR: KEEVIN GILLESPIE

Issuer

Yes

For

For

1c ELECTION OF DIRECTOR: DELRAY WANNEMACHER

Issuer

Yes

For

For

1d ELECTION OF DIRECTOR: KING FAI LEUNG

Issuer

Yes

For

For

1e ELECTION OF DIRECTOR: SHELBY CHAN

Issuer

Yes

For

For

2 SELECTION OF B F BORGERS CPA PC AS OUR AUDIT FIRM FOR

Issuer

Yes

For

For

FY 2020

3 AMENDMENT TO THE COMPANY'S CERTIFICATE OF

Issuer

Yes

For

For

INCORPORATION TO INCREASE THE COMPANY'S AUTHORIZED

SHARES OF COMMON STOCK FROM 80,000,000 TO 700,000,000

SHARES AND TO INCREASE THE COMPANY'S AUTHORIZED

SHARES OF PREFERRED STOCK FROM 20,000,000 TO 300,000,000

SHARES

4 APPROVAL OF THE COMPANY'S 2019 AMENDED EQUITY

Issuer

Yes

For

For

INCENTIVE PLAN

5 ADVISORY VOTE TO APPROVE THE COMPANY'S EXECUTIVE

Issuer

Yes

For

For

COMPENSATION

6 AN ADVISORY RESOLUTION TO APPROVE THE FREQUENCY OF THE

Issuer

Yes

1 Year

1 Year

COMPANY'S "SAY ON PAY" VOTE

10/24/2019 Microsoft

MSFT

594918

12/4/2019

1A Election of Director: William H. Gates III

Issuer

Yes

For

For

10/25/2019

1B Election of Director: Reid G. Hoffman

Issuer

Yes

For

For

1C Election of Director: Hugh F. Johnston

Issuer

Yes

For

For

1D Election of Director: Teri L. List-Stoll

Issuer

Yes

For

For

1E Election of Director: Satya Nadella

Issuer

Yes

For

For

1F Election of Director: Sandra E. Peterson

Issuer

Yes

For

For

1G Election of Director: Penny S. Pritzker

Issuer

Yes

For

For

1H Election of Director: Charles W. Scharf

Issuer

Yes

For

For

1I Election of Director: Arne M. Sorenson

Issuer

Yes

For

For

1J Election of Director: John W. Stanton

Issuer

Yes

For

For

1K Election of Director: John W. Thompson

Issuer

Yes

For

For

1L Election of Director: Emma Walmsley

Issuer

Yes

For

For

American Growth Fund, Inc. (Series 2)

NPX - Proxy Voting Record

From July 1, 2019 to June 30, 2020

Shareholder

Proposals / Identification

Cast its Vote

Recommendations of the

Cast its Vote for or

Date

Date Notified

Company

Symbol

CUSIP

Meeting Date

Voted on

Proposed

Yes or No

Board of Directors

Against Management

Voted

1M Election of Director: Padmasree Warrior

Issuer

Yes

For

For

2 Advisory vote to approve named executive officer compensation

Issuer

Yes

For

For

3 Ratification of Deloitte & Touche LLP as our independent auditor for fiscal year

Issuer

Yes

For

For

2020

4 Shareholder Proposal - Report on Employee Representation on Board of Directors

Issuer

Yes

Against

For

5 Shareholder Proposal - Report on Gender Pay Gap

Issuer

Yes

Against

For

12/21/2019 The Scotts Miracle-Gro Company

SMG

810186106

1/27/2020

1 DIRECTOR

12/27/2019

James Hagedorn

Issuer

Yes

For All

For All

Brian D. Finn

Issuer

Yes

For All

For All

Nancy G. Mistretta

Issuer

Yes

For All

For All

2 Approval, on an advisory basis, of the compensation of the Company's named

Issuer

Yes

For

For

executive officers.

3 Ratification of the selection of Deloitte & Touche LLP as the Company's

Issuer

Yes

For

For

independent registered public accounting firm for the fiscal year ending September

30, 2020.

3/20/2020 22ND CENTURY GROUP, INC. XXII

90137

F103

5/1/2020

1 DIRECTOR

Issuer

Yes

For All

For All

3/20/2020

Clifford B. Fleet

Roger D. O'Brien

2 To approve, by non-binding vote, 2019 executive compensation.

Issuer

Yes

For

For

3 Ratification of the appointment of Freed Maxick CPAs as the independent

Issuer

Yes

For

For

registered public accounting firm.

3/19/2020 ABBOTT LABORATORIES

ABT

2824100 04/24

//2020

1 DIRECTOR

Issuer

Yes

For All

For All

3/20/2020

R.J. Alpern

R.S. Austin

S.E. Blount

R.B. Ford

M.A. Kumbier

E.M. Liddy

D.W. McDew

N. McKinstry

P.N. Novakovic

W.A. Osborn

D.J. Starks

J.G. Stratton

G.F. Tilton

M.D. White

2 Ratification of Ernst & Young LLP as Auditors.

Issuer

Yes

For

For

3 Say on Pay - An Advisory Vote to Approve Executive Compensation.

Issuer

Yes

For

For

4 Shareholder Proposal - Lobbying Disclosure.

Issuer

Yes

Against

For

5 Shareholder Proposal - Non-GAAP Financial Performance Metrics Disclosure.

Issuer

Yes

Against

For

6 Shareholder Proposal - Shareholder Voting on By-Law Amendments.

Issuer

Yes

Against

For

7 Shareholder Proposal - Simple Majority Vote.

Issuer

Yes

Against

For

3/27/2020 ABBIE VIE

ABBV

00287

Y109

5/8/2020

1 DIRECTOR

Issuer

Yes

For All

For All

3/27/2020

Robert J. Alpern

Edward M. Liddy

Melody B. Meyer

Frederick H. Waddell

2 Ratification of Ernst & Young LLP as AbbVie's independent registered public

Issuer

Yes

For

For

accounting firm for 2020

3 Say on Pay - An advisory vote on the approval of executive compensation

Issuer

Yes

For

For

4 Approval of a management proposal regarding amendment of the certificate of

Issuer

Yes

Yes

For

incorporation to eliminate supermajority voting

5 Stockholder Proposal - to Issue an Annual Report on Lobbying

Issuer

Yes

Against

For

6 Stockholder Proposal - to Adopt a Policy to Require Independent Chairman

Issuer

Yes

Against

For

7 Stockholder Proposal - to Issue a Compensation Committee Report on Drug Pricing

Issuer

Yes

Against

For

American Growth Fund, Inc. (Series 2)

NPX - Proxy Voting Record

From July 1, 2019 to June 30, 2020

Shareholder

Proposals / Identification

Cast its Vote

Recommendations of the

Cast its Vote for or

Date

Date Notified

Company

Symbol

CUSIP

Meeting Date

Voted on

Proposed

Yes or No

Board of Directors

Against Management

Voted

3/21/2020 BAUSCH HEALTH

BHC

071734107

4/27/2020

1a Election of Director: Richard U. De Schutter

Issuer

Yes

For

For

3/27/2020

COMPANIES, INC.

1b Election of Director: D. Robert Hale

Issuer

Yes

For

For

1c Election of Director: Dr. Argeris (Jerry) N. Karabelas

Issuer

Yes

For

For

1d Election of Director: Sarah B. Kavanagh

Issuer

Yes

For

For

1e Election of Director: Joseph C. Papa

Issuer

Yes

For

For

1f Election of Director: John A. Paulson

Issuer

Yes

For

For

1g Election of Director: Robert N. Power

Issuer

Yes

For

For

1h Election of Director: Russel C. Robertson

Issuer

Yes

For

For

1j Election of Director: Thomas W. Ross, Sr.

Issuer

Yes

For

For

1k Election of Director: Amy B. Wechsler, M.D.

Issuer

Yes

For

For

2 The approval, in an advisory vote, of the compensation of our Named Executive

Issuer

Yes

For

For

Officers.

3 The approval of an amendment to the Company's Amended and Restated 2014

Issuer

Yes

For

For

Omnibus Incentive Plan to increase the number of Common Shares authorized

under such plan.

4 To appoint PricewaterhouseCoopers LLP as the auditors for the Company to hold

Issuer

Yes

For

For

office until the close of the 2021 Annual Meeting of Shareholders and to authorize

the Company's Board of Directors to fix the auditors' remuneration.

4/2/2020 CBDMD, INC.

YCBD

12482

W101

4/23/2020

1 DIRECTOR

Issuer

Yes

For All

For All

4/3/2020

Martin A. Sumichrast

R. Scott Coffman

Bakari Sellers

Peter J. Ghiloni

Scott G. Stephen

William F. Raines, III

2 The ratification of the appointment of Cherry Bekaert LLP as the Company's

Issuer

Yes

For

For

independent registered public accounting firm

4/16/2020 CORBUS PHARMACEUTICALS CRBP

21833

P103

5/20/2020

1 DIRECTOR

Issuer

Yes

For

For

4/17/2020

HOLDINGS, INC.

Yuval Cohen

Alan Holmer

David P. Hochman

Avery W. Catlin

Peter Salzmann

John Jenkins

Rachelle Jacques

2 Ratification of EisnerAmper LLP as the Company's independent registered public

Issuer

Yes

For

For

accounting firm for the year ending December 31, 2020.

3 Approval, on an advisory basis, of the executive compensation of the Company's

Issuer

Yes

For

For

named executive officers.

4 To vote, on an advisory basis, on how often the Company will conduct an advisory

Issuer

Yes

1 Year

For

vote on executive compensation

4/11/2020 GW PHARMACEUTICALS PLC

GWPH

36197

T103

5/26/2020

1 To re-elect Dr. Geoffrey W. Guy as a Director

Issuer

Yes

For

For

4/17/2020

2 To re-elect Cabot Brown as a Director

Issuer

Yes

For

For

3 To approve the 2020 Long Term Incentive Plan

Issuer

Yes

For

For

4 To approve the Directors' Remuneration Report

Issuer

Yes

For

For

5 To approve the compensation of the Company's named executive officers

Issuer

Yes

For

For

6 To ratify the appointment of Deloitte and Touche LLP as the Company's US public

Issuer

Yes

For

For

accounting firm

7 To re-appoint Deloitte LLP as the UK Auditor

Issuer

Yes

For

For

8 To authorise the Directors to determine the Auditors' remuneration

Issuer

Yes

For

For

9 To receive, consider and adopt the Directors' and Auditors' Reports and Statement

Issuer

Yes

For

For

of Accounts for the 12-month period ended 31 December 2019 and note that the

Directors do not recommend the payment of a dividend

10 To authorise the Directors to allot shares pursuant to Section 551 of the Companies

Issuer

Yes

For

For

Act 2006 (the "2006 Act") such authority to be valid up to 26 May 2021

American Growth Fund, Inc. (Series 2)

NPX - Proxy Voting Record

From July 1, 2019 to June 30, 2020

Shareholder

Proposals / Identification

Cast its Vote

Recommendations of the

Cast its Vote for or

Date

Date Notified

Company

Symbol

CUSIP

Meeting Date

Voted on

Proposed

Yes or No

Board of Directors

Against Management

Voted

11 Subject to the passing of Resolution 10, to authorise the Directors to allot equity

Issuer

Yes

For

For

securities, under Section 570 of the 2006 Act as if Section 561(1) of the 2006 Act

did not apply to such allotment

4/24/2020 TELADOC HEALTH, INC.

TDOC

87918

A105

5/28/2020

1 DIRECTOR

Issuer

Yes

For All

For All

4/24/2020

Ms. Helen Darling

Mr. William H. Frist MD

Mr. Michael Goldstein

Mr. Jason Gorevic

Ms. C. A. Jacobson

Mr. Thomas G. McKinley

Mr. Kenneth H. Paulus

Mr. David Shedlarz

Mr. Mark D. Smith, MD

Mr. David B. Snow, Jr.

2 Approve, on an advisory basis, the compensation of Teladoc Health's named

Issuer

Yes

For

For

executive officers.

3 Ratify the appointment of Ernst & Young LLP as Teladoc Health's independent

Issuer

Yes

For

For

registered public accounting firm for the fiscal year ending December 31, 2020.

4/21/2020 MERCK & CO., INC.

MRK

58933

Y105

5/26/2020

1a Election of Director: Leslie A. Brun

Issuer

Yes

For

For

4/24/2020

1b Election of Director: Thomas R. Cech

Issuer

Yes

For

For

1c Election of Director: Mary Ellen Coe

Issuer

Yes

For

For

1d Election of Director: Pamela J. Craig

Issuer

Yes

For

For

1e Election of Director: Kenneth C. Frazier

Issuer

Yes

For

For

1f Election of Director: Thomas H. Glocer

Issuer

Yes

For

For

1g Election of Director: Risa Lavizzo-Mourey

Issuer

Yes

For

For

1h Election of Director: Paul B. Rothman

Issuer

Yes

For

For

1i Election of Director: Patricia F. Russo

Issuer

Yes

For

For

1j Election of Director: Christine E. Seidman

Issuer

Yes

For

For

1k Election of Director: Inge G. Thulin

Issuer

Yes

For

For

1l Election of Director: Kathy J. Warden

Issuer

Yes

For

For

1m Election of Director: Peter C. Wendell

Issuer

Yes

For

For

2 Non-binding advisory vote to approve the compensation of our named executive

Issuer

Yes

For

For

officers.

3 Ratification of the appointment of the Company's independent registered public

Issuer

Yes

For

For

accounting firm for 2020.

4 Shareholder proposal concerning shareholder right to act by written consent.

Issuer

Yes

Against

For

5 Shareholder proposal regarding allocation of corporate tax savings.

Issuer

Yes

Against

For

4/29/2020 REGENERON

REGN

75886

F107

6/12/2020

1a Election of Director: N. Anthony Coles, M.D.

Issuer

Yes

For

For

PHARMACEUTICALS, INC.

1b Election of Director: Joseph L. Goldstein, M.D.

Issuer

Yes

For

For

1c Election of Director: Christine A. Poon

Issuer

Yes

For

For

1d Election of Director: P. Roy Vagelos, M.D.

Issuer

Yes

For

For

1e Election of Director: Huda Y. Zoghbi, M.D.

Issuer

Yes

For

For

2 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's

Issuer

Yes

For

For

independent registered public accounting firm for the fiscal year ending December

31, 2020.

3 Proposal to approve the Second Amended and Restated Regeneron

Issuer

Yes

For

For

Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan.

4 Proposal to approve, on an advisory basis, executive compensation.

Issuer

Yes

For

For

4/28/2020 CARA THERAPEUTICS, INC.

CARA

140755109

6/4/2020

1 DIRECTOR

Issuer

Yes

For All

For All

Derek Chalmers PhD, DSc

Issuer

Yes

Martin Vogelbaum

Issuer

Yes

2 Advisory vote to approve the compensation of our named executive officers.

Issuer

Yes

For

For

3 Advisory vote to approve the frequency of future non-binding advisory votes to

Issuer

Yes

1 Year

For

approve the compensation of our named executive officers.

4 Ratification of the appointment of Ernst & Young LLP as the registered public

Issuer

Yes

For

For

accounting firm for the fiscal year ending December 31, 2020.

American Growth Fund, Inc. (Series 2)

NPX - Proxy Voting Record

From July 1, 2019 to June 30, 2020

Shareholder

Proposals / Identification

Cast its Vote

Recommendations of the

Cast its Vote for or

Date

Date Notified

Company

Symbol

CUSIP

Meeting Date

Voted on

Proposed

Yes or No

Board of Directors

Against Management

Voted

6/2/2020 Power REIT

PW

73933

H101

6/24/2020

1 DIRECTOR

Issuer

Yes

For All

For All

6/5/2020

David H. Lesser

Virgil E. Wenger

Patrick R. Haynes, III

William S. Susman

2 Ratification of appointment of MaloneBailey LLP as the Trust's independent

Issuer

Yes

For

For

registered public accounting firm.

3 Approve the 2020 Equity Incentive Plan.

Issuer

Yes

For

For

6/9/2020 CONSTELLATION BRANDS,

STZ

21036

P108

7/21/2020

1 DIRECTOR

Issuer

Yes

For All

For All

6/12/2020

INC.

Christy Clark

Jennifer M. Daniels

Jerry Fowden

Ernesto M. Hernandez

S. Somersille Johnson

James A. Locke III

J. Manuel Madero Garza

Daniel J. McCarthy

William A. Newlands

Richard Sands

Robert Sands

Judy A. Schmeling

2 To ratify the selection of KPMG LLP as the Company's independent registered

Issuer

Yes

For

For

public accounting firm for the fiscal year ending February 28, 2021.

3 To approve, by an advisory vote, the compensation of the Company's named

Issuer

Yes

For

For

executive officers as disclosed in the Proxy Statement.

6/17/2020 AKERNA CORP.

KERN

00973

W102

6/26/2020

1 Approval of the issuance of shares of Akerna common stock upon the exchange of

Issuer

Yes

For

For

6/19/2020

Exchangeable Shares, as further described in the proxy statement (the "Stock

Issuance").

2 Approval of the Arrangement.

Issuer

Yes

For

For

3 Approval of the Solo Option.

Issuer

Yes

For

For

4 Approval of the Incentive Plan Amendment.

Issuer

Yes

For

For

5 Approval to adjourn the Special Meeting, to permit further solicitation, if there are

Issuer

Yes

For

For

not sufficient votes.